The case of Patient No. 6, who developed vulvar dermatofibrosarcoma protuberans with COL1A1-PDGFB fusion, illustrates the potential utility of molecular characterization in guiding therapy [18]. Here, COL1A1 is linked to dermatofibrosarcoma protuberans.